Intest Corp Earnings Call Signals Cautious Recovery

Intest Crop ((INTT)) has held its Q4 earnings call. Read on for the main highlights of the call.

Intest Corp’s latest earnings call struck a tone of cautious optimism, as management highlighted a sharp fourth-quarter rebound, healthier margins and growing diversification away from semiconductors, even while acknowledging that full-year 2025 results showed weaker revenue and profitability and that the outlook still hinges on a fragile macro and semiconductor demand backdrop.

Q4 Revenue Rebound Caps Challenging Year

Q4 revenue climbed to $32.8 million, beating guidance and marking the company’s strongest quarter of the year, with sales rising 25% sequentially from $26.2 million in Q3, helped by roughly $2 million of shipments that slipped from the prior quarter and underscoring a clear turn from the Q3 trough.

Orders Surge and Backlog Builds Multi‑Year Visibility

Quarterly orders surpassed $37 million and grew 22% year over year, pushing year‑end backlog to $53.9 million, up 36% from a year ago and 9% sequentially, and with about 60% of that backlog expected to ship beyond 2026, investors gain longer‑term visibility even though a large slice of revenue sits further out.

Gross Margins Expand on Mix and New Products

Gross margin in Q4 expanded to 45.4%, up 350 basis points sequentially and 570 basis points from the prior year period, driven by higher volumes and a richer mix of newer, higher‑margin Alphamation offerings, while normalized full‑year gross margin of roughly 43% suggests structural improvement versus earlier in the cycle.

Q4 Profitability Metrics Show Clear Improvement

Net income in Q4 reached $1.2 million and adjusted EBITDA rose to $3.2 million, translating into a 9.7% margin versus just 1.5% in Q3, and diluted earnings per share of $0.10, or $0.16 on an adjusted basis, confirmed that operating leverage is returning as volumes recover.

Diversification Beyond Semiconductors Gains Traction

Nearly 80% of Q4 revenue came from non‑semiconductor end markets as life sciences orders tripled sequentially and full‑year demand in life sciences, auto EV and industrial rose 137%, 89% and 53% respectively, while new platforms like Alphamation and Archaeologic are accelerating progress toward the company’s Vision 2030 goal of deriving a quarter of revenue from new products.

Debt Reduction Strengthens Balance Sheet and Liquidity

Management trimmed debt by $1.4 million in Q4 and $7.6 million over 2025, leaving total debt at $7.5 million and access to roughly $58 million of total liquidity including $18.1 million of cash plus undrawn capacity on a delayed‑draw term loan and revolver, which together provide ample flexibility to fund growth and navigate volatility.

Efficiency Gains Support Margins Despite Weak Semi

Manufacturing efficiency initiatives, scaling the company’s Malaysia operations and broader cost actions helped lower operating expenses as a share of revenue to 41.5% in Q4, aiding margin expansion even though semiconductor contributions remained relatively subdued and underscoring management’s focus on disciplined execution.

Full‑Year Profitability Reflects Tougher 2025 Comparisons

For 2025, Intest posted a net loss of $2.5 million and adjusted EBITDA of $4.0 million for a 3.5% margin, down sharply from $10.8 million and an 8.3% margin in 2024, highlighting how the year’s macro and industry headwinds weighed on profitability despite the stronger finish in Q4.

Revenue Hit by Semiconductor Slump and Slower Capex

Revenue for 2025 fell about $17 million from 2024, with roughly three quarters of the decline tied to semiconductor market weakness and the rest reflecting slower‑than‑expected capital spending in other end markets, while Q4 revenue was still $3.8 million below the prior year quarter and semiconductor revenue dropped $2.9 million sequentially.

Semi Market Weakness and Modest Recovery Assumptions

Semiconductor exposure remained under pressure with semi orders representing roughly 25% of Q4 activity versus 40% in 2024, and management explicitly built only a modest semi recovery into their 2026 outlook, leaving the company exposed if the timing of any broader semiconductor upturn slips.

EPS Compression Underscores Earnings Pressure

Adjusted net income for 2025 totaled just $0.8 million, or $0.06 per share, compared with adjusted EPS of $0.51 in 2024, underscoring how lower volumes and mix shifts translated into much tighter per‑share earnings even as cost controls and margin improvements began to take hold late in the year.

Opex and One‑Time Items Cloud Comparisons

Operating expenses in Q4 increased $1.4 million sequentially to $13.6 million, mainly due to higher sales commissions and marketing investments, while year‑over‑year comparisons were skewed by an $800,000 amortization credit in the prior‑year quarter and about $200,000 of restructuring charges in Q4 2025, making trend analysis more nuanced for investors.

Covenant Waiver Highlights Prior Financing Strain

The company operated under a waiver on its term loan agreed in August, signaling earlier covenant pressure despite solid liquidity, and management expects to return to full covenant compliance by midyear, which would remove a key overhang and restore a more normal financing posture.

Backlog Timing a Double‑Edged Sword

With around 60% of backlog slated to ship after 2026, Intest enjoys multi‑year revenue visibility that supports long‑term planning, but that same concentration means a considerable portion of future sales is pushed out and could be delayed if customer investment plans change with the macro cycle.

2026 Outlook Points to Gradual Recovery

Management guided Q1 2026 revenue to $31–33 million with about 44% gross margin and operating expenses around the mid‑$13 million range, and for the full year they project $125–130 million of revenue, roughly 12% growth at the midpoint with gross margin near 45%, operating expenses of $53–55 million, modest interest costs and low single‑digit capex as they plan for growth without assuming a major semiconductor rebound or significant tariff and geopolitical disruption.

Intest’s earnings call portrayed a company exiting a difficult 2025 with stronger Q4 momentum, improved margins and a healthier balance sheet, yet still contending with semiconductor weakness and softer capital spending, leaving investors to weigh a more diversified and better‑positioned business against near‑term earnings pressure and macro‑sensitive demand as they look toward 2026 and beyond.